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a r t I C l e S
The ability of the nervous system to communicate with the periphery depends on faithful transmission of information to target tissues through peripheral nerves. The speed of propagation of action potentials in these nerves depends on myelin, which is formed by Schwann cells. Impaired differentiation of Schwann cells or damage to myelin results in debilitating peripheral neuropathies 1 . Given the clinical relevance of PNS myelination, it is not surprising that it has been the focus of several mechanistic studies. Investigation of the molecules at the axon-Schwann cell interface that trigger myelination led to the discovery of type III neuregulin1 (refs. 2-4) . This axon-derived signal modulates almost every aspect of Schwann cell development and interacts with erbB2 and erbB3 receptors to initiate a signaling cascade that is essential for modulating the timing and abundance of myelin formation in peripheral nerves 2, [4] [5] [6] [7] .
Many transcription factors also modulate Schwann cell differentiation, including Egr2, Pou3f1 (also known as Oct-6), Sox10, Brn1 and Brn2 (refs. 8-13) . Among them, a key modulator of the transcriptional program of peripheral myelination is Egr2, a zinc finger transcription factor that is regulated by axonal contact and is induced as Schwann cells begin to myelinate. Analysis of Egr2-deficient mice and correlation of mutations in EGR2 with human peripheral neuropathies have provided compelling evidence that Egr2 is important for myelination of peripheral nerves 10, 14, 15 . Gene expression studies have revealed that Egr2 acts as a positive regulator of the myelination process 16, 17 although the molecular mechanisms that regulate its expression remain only partially understood. Egr2 is regulated by both soluble and membrane-bound neuregulins 4, 16, 18 and its concentration is partially modulated by calcium-dependent events 19 .
Together these studies have indicated that peripheral myelination is the result of the interplay between extracellular signals and an intricate network of transcription factors, orchestrated by Egr2. However, many of the molecular connections between cell surface receptors and transcription factors that modulate myelination are unknown. We have identified the zinc finger protein YY1 as an important modulator of PNS myelination downstream of neuregulin1 (NRG1) signaling. The MEK-dependent cascade that was initiated by NRG1 treatment was responsible for activation of YY1 and increased expression of Egr2. In addition, Schwann cells that lacked YY1 owing to silencing or genetic ablation had low levels of Egr2 and showed impaired myelin gene expression, a phenotype that could be rescued by overexpression of Egr2.
RESULTS

Severe hypomyelination in sciatic nerves lacking Yy1
We generated mutants with conditional ablation of Yy1 in myelinating cells by crossing Yy1 loxP-flanked mice with the Cnp-cre line as described previously 20 . Although the mice were viable, the number of survivors decreased with age and dropped markedly after the third postnatal week (Supplementary Fig. 1a ). In addition, surviving mice did not gain as much weight as their control siblings (Supplementary Fig. 1b) . Heterozygous Yy1 mice (Yy1 loxP/+ ; Cnp-cre +/− ) appeared normal and were used as littermate controls. We detected clinical signs of peripheral hypomyelination in the homozygous Yy1 mutants (Yy1 loxP/loxP ; Cnp-cre +/− ) during the second postnatal week; they were characterized by hindlimb weakness, flaccid tail paralysis and abnormal hindlimb posture reflexes (Fig. 1) . The onset of clinical signs was consistent with the temporal profile of Yy1 expression in the developing sciatic nerve. Yy1 was expressed at birth, but its transcript levels peaked at postnatal day (P)10 and its expression profile closely resembled that of Egr2 during development 10, 21 (Fig. 1b) . Consistent with its role as transcription factor, we found YY1 in the nuclei of myelinated Schwann cells in wild-type mice (Fig. 1c) but not in the sciatic nerves of Yy1 loxP/loxP ; Cnp-cre +/− mice (Fig. 1d) .
Macroscopic examination of the sciatic nerves showed hypomyelination; the nerves were thick and opaque white in control mice and thin and translucent in Yy1 mutants (Fig. 1e) . At the molecular level, the sciatic nerves of Yy1 loxP/loxP ; Cnp-cre +/− mice had lower levels of myelin gene transcripts than did those of control siblings. The differences in transcripts, including myelin protein zero (Mpz) and peripheral myelin protein 22 (Pmp22), between Yy1 loxP/loxP ; Cnp-cre +/− and control siblings were not evident at P1, but became statistically significant at P10 and persisted throughout development (Fig. 1f) . Immunohistochemical analysis of MPZ confirmed the severe hypomyelination at P10 and P18 in the sciatic nerve of Yy1 loxP/loxP ; Cnp-cre +/− mice and supported the idea that YY1 is important for myelination from P10 (Fig. 1g) . At the ultrastructural level, the sciatic nerves of Yy1 loxP/loxP ; Cnp-cre +/− mice at P18 had very few myelinated axons (14.3 ± 6.3%, total of 692 axons counted and three mice analyzed) compared with controls (54.7 ± 8.5%, 779 axons counted and three mice analyzed; Fig. 2a) . The myelinated axons detected in Yy1 loxP/loxP ; Cnp-cre +/− mice had thinner myelin sheaths, as indicated by the greater g ratio (ratio of axon diameter to the myelinated fiber diameter) in Yy1 mutants (0.853 ± 0.076) compared with controls (0.691 ± 0.088; Fig. 2b) .
In Yy1 loxP/loxP ; Cnp-cre +/− mice we detected Schwann cells in a 1:1 relationship with large caliber axons (>1 μm), but the percentage of unmyelinated large caliber axons was much greater than in controls (Fig. 2c) . Because peripheral nerve myelination proceeds in sequential stages that include the association of Schwann cells with clustered axons, followed by radial sorting and 1:1 segregation with the axon 1 , our data suggested that the sorting process was not affected in Yy1 loxP/loxP ; Cnp-cre +/− mice and that only the late stages of myelination were impaired. In addition, high levels of Pou3f1 (a marker of pro-myelinating cells) persisted in Yy1 loxP/loxP ; Cnp-cre +/− mice (Fig. 2d,e) . Consistent with impaired developmental myelination, we rarely saw adjacent myelin segments in Yy1 loxP/loxP ; Cnp-cre +/− sciatic nerves and we noted the prevalence of heminodes (half of a node characterized by the presence of an unpaired paranode; Fig. 2f) . The ultrastructural appearance of heminodes in Yy1 mutants at P18 was consistent with the immunohistochemical detection of unpaired clusters of contactin-associated paranode protein (Caspr) labeling (Fig. 2f) . This further confirmed the hypomyelinating phenotype.
We also observed defective myelination in the absence of Yy1 in vitro, in dorsal root ganglia (DRG) explants (Supplementary Fig. 2a,b) , which contained neurons and Schwann cell precursors 22 . In explants from control siblings DRG axons were effectively myelinated (18.1 ± 4.7 myelin segments per field; Fig. 3a) , whereas myelination was rare in explants from Yy1 loxP/loxP ; Cnp-cre +/− mice (2.1 ± 1.1 myelin segments per field; Fig. 3b ). The lack of myelinated segments correlated with low levels of myelin gene transcripts (Fig. 3c) and severely decreased myelin protein levels, as detected by protein blot (Fig. 3d) . To further characterize the effect of YY1 on Schwann cell myelination, we repeated the experiment with DRG explants isolated from Yy1 loxP/loxP ;Plp-CreER T embryos 23 Fig. 3e,f) . We determined the efficiency of recombination in myelinating Schwann cells by treating cultures with 10 nM, 100 nM and 1 μM 4-hydroxy-tamoxifen (4OH-TM) for 48 h and assaying the nuclear localization of Cre and the expression of YY1 using immunocytochemistry (Supplementary Fig. 2c ). As expected, 4OH-TM induced nuclear translocation of Cre in a dose-dependent fashion only in Schwann cells, but not in fibroblasts and neurons, that continued to express YY1 (Supplementary Fig. 2c ). The analysis of myelin segments in explants treated with 1 μM 4OH-TM (Fig. 3f) revealed only 2.2 ± 0.6 myelin segments per field compared to 20.5 ± 4.9 segments in mock-treated explants and 15.3 ± 2.9 segments in Yy1 loxP/loxP explants treated with 4OH-TM (Fig. 3e) . To confirm that defective myelination in the Yy1 loxP/loxP ; Cnp-cre +/− explants depended on the Schwann cells and not on the DRG neurons, we generated co-cultures of wild-type rat Schwann cells with DRG neurons from Yy1 loxP/loxP ; Cnp-cre +/− or control embryos (Fig. 3g) . Both cultures showed similar numbers of myelin segments, which supports the idea that the defect in the Yy1 loxP/loxP ; Cnp-cre +/− mice depended on Schwann cell function.
YY1 is an important upstream regulator of Egr2
We reasoned that the mechanism of action of YY1 in Schwann cells might involve Egr2 because the two transcripts shared a similar expression profile in the developing sciatic nerve and because of the marked similarities between the phenotype of the 17 . In all three mutant mice, similar clinical signs developed during the second postnatal week and included tremor and weakness of the hind limbs. The macroscopic appearance of the sciatic nerves was identical (thin and translucent) and the Schwann cells in the three mutants showed successful completion of radial sorting and defective myelination 10, 14, 17 . Because Egr2 Lo/Lo (refs. 10,14,24) and Nab1 −/− ;Nab2 −/− double mutants 17 showed increased proliferation and apoptosis compared to control mice, we investigated whether similar features occurred in the Yy1 loxP/loxP ; Cnp-cre +/− mice. We used BrdU incorporation to measure S-phase entry and performed immunohistochemical analysis of the sciatic nerve of Yy1 mutant and control mice at P1, P10 and P18 (Fig. 4a,b) . Although we detected no difference at the early developmental time points, similar to the Egr2 Lo/Lo mice 14 , we found a higher percentage of BrdU + cells in the sciatic nerves of Yy1 loxP/loxP ; Cnp-cre +/− mice than in those of controls at P10 and P18 (Fig. 4b) . The detection of a proliferative phenotype at p10, but not at p1, in Yy1 loxP/loxP ; Cnp-cre +/− mice was consistent with the developmental pattern of Yy1 expression in the sciatic nerve and correlated with the downregulation of the cell cycle inhibitor Cdkna1 (also called p21), which is an important regulator of the G1-S phase transition (Fig. 4c) . We detected similar results in DRG co-cultures from Yy1 loxP/loxP ; Cnp-cre +/− mice and controls ( Supplementary  Fig. 3 ). We next examined apoptosis in the sciatic nerves. Although we found no difference at P2 or P10, we detected a transient and modest increase in TUNEL + cells at P18 in Yy1 loxP/loxP ; Cnp-cre +/− mice compared with controls ( Fig. 4d) . This was associated with increased transcripts of genes involved in apoptosis, such as Jun and Tgfb1 (refs. 25,26; Fig. 4e ). Together, these data suggested that there might be a genetic interaction between YY1 and Egr2.
To investigate this possibility, we compared gene profiling of the sciatic nerves from control and Yy1 loxP/loxP ; Cnp-cre +/− mice at P21 and identified 1,575 upregulated genes and 1,151 downregulated genes. We then compared this set of 2,725 genes with published gene profiling datasets from Egr2 Lo/Lo and Nab1 −/− ;Nab2 −/− mice 17 . 
a r t I C l e S
Among the genes whose expression changed in Yy1 mutants, 36.67% were also changed in Egr2 Lo/Lo mice and 24.60% were also altered in Nab1 −/− ;Nab2 −/− mice. Of the regulated genes, 351 overlapped in all three mutants (Fig. 5a ). The shared subsets of genes that had decreased expression included the myelin genes Pmp22, Mpz and Mbp, and those encoding lipid metabolism enzymes such as stearoylcoenzyme A desaturase 2 (Scd2), fatty acid desaturase 2 (Fads2), 24-dehydrocholesterol reductase (Dhcr24) and HMG coenzyme A reductase (Hmgcr; Fig. 5b ), and this is consistent with the hypomyelinating phenotype and with the involvement of these genes in several human neuropathies. Additional transcripts that were significantly decreased in all three mutants included several growth factors such as fibroblast growth factor 1 (Fgf1), Fgf4 and bone morphogenetic protein 7 (Bmp7), and receptors such as Frizzled-related protein 3 (Frzb) and G protein-coupled receptor family C group 5 (Gprc5b). The transcripts that were upregulated during the third postnatal week in all three mutants included the transcription factors Sox4, Sox5, Egr1, Pou3f1, Btg1, Id2 and Id4 (refs. 27,28; Fig. 5b ) and also genes related to the cell cycle such as cyclin B1 (Ccnb1), cyclin D1 (Ccnd1), cell division cycle associated 3 (Cdca3) and pituitary tumor-transforming 1 (Pttg1).
The similarity between the gene expression signatures in the sciatic nerves of Egr2 Lo/Lo mice and Yy1 loxP/loxP ; Cnp-cre +/− mice was consistent with a possible interaction between YY1 and the Egr2-Nab regulatory network. As the levels of Yy1 transcript changed only slightly in Egr2 Lo/Lo mice (1.2-fold) and in Nab1 −/− ;Nab2 −/− mice (0.95-fold) 14, 17 , it was unlikely that Yy1 was downstream of the Egr2-Nab complex. An alternative possibility was that Yy1 was upstream of Egr2. Indeed, levels of Egr2 transcripts in the sciatic nerve of Yy1 loxP/loxP ; Cnp-cre +/− mice were significantly lower than control values at P10 and reached 38 ± 8% of control levels at P21 (Fig. 5c) . Levels of 
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VOLUME 13 | NUMBER 12 | DECEMBER 2010 nature neurOSCIenCe a r t I C l e S Nab1 transcript were less affected in Yy1 loxP/loxP ; Cnp-cre +/− mice (62 ± 6.3% of the level of the controls, n = 3) and Nab2 transcripts were increased (70% more than controls), which suggests that the effect of Yy1 on myelination was unlikely to be mediated by the modulation of Nab1 and Nab2 levels (Fig. 5d) . The decrease in Egr2 transcripts in Yy1 loxP/loxP ; Cnp-cre +/− mice was consistent with the detection of decreased levels of Egr2 protein by immunohistochemistry (Fig. 5e ) and protein blot (Fig. 5f) . To prove that Egr2 was downstream of YY1, we overexpressed Egr2 in Yy1 loxP/loxP ; Cnp-cre +/− Schwann cells; this overexpression rescued the expression of MPZ (Fig. 5f ). Together these data provide strong evidence that YY1 is an upstream regulator of Egr2.
To investigate whether the hypomyelinating phenotype of Yy1 mutants resulted from changes in the expression of genes that negatively affect postnatal peripheral myelination, we searched the microarray database for enrichment in genes in the Notch signaling pathway 29 . We also searched for genes related to the neuregulincalcineurin-NFATcy pathway, which modulates Schwann cell differentiation 19 . Pathway analysis conducted with the DAVID Gene Functional Classification Tool did not reveal any enrichment of genes associated with these two signaling pathways (data not shown). To test further whether the decrease in Egr2 transcripts in Yy1 loxP/loxP ; Cnpcre +/− mice resulted from altered Notch signaling, we performed protein blot analysis and quantitative real-time PCR. The decreased levels of the intracellular domain of Notch (NICD) detected in Yy1 loxP/loxP ; Cnp-cre +/− mice (Fig. 5g) , together with the similar levels of Notch1 and its ligand Jagged1 throughout development (Fig. 5h) , ruled out the involvement of this pathway in the hypomyelinating phenotype of the mutants. Similarly, the pattern of expression of calcineurin B (Cnb1, also known as Ppp3r1; Fig. 5h ) and the lack of similarities between the phenotypes of Yy1 loxP/loxP ; Cnp-cre +/− and Ppp3r1 mutant mice suggested that YY1 acts as upstream regulator of Egr2, independent of calcineurin B or Notch signaling.
NRG1-dependent YY1 phosphorylation regulates Egr2
The expression of Egr2 expression is crucial for peripheral nerve myelination and is regulated by axonal contact and soluble neuregulin 4, 17 . Treatment of cultured Schwann cells 17, 18 with soluble NRG1 for 1 h was sufficient to induce upregulation of Egr2 transcripts (Fig. 6a) . To determine whether YY1 was part of the signaling pathway that was responsible for the upregulation of Egr2 in response to NRG1, we silenced its expression using short hairpin RNA (shRNA) plasmids transfected into primary Schwann cells (Fig. 6b) and measured the transcript levels (Fig. 6c) . Yy1 silencing significantly decreased the NRG1-mediated expression of Egr2 transcripts (Fig. 6c) whereas the levels of Nab1, Nab2 and Pou3f1 transcripts remained unchanged (Fig. 6d) .
The role of YY1 in regulating the NRG-induced expression of Egr2 was consistent with the presence of multiple YY1 binding sites in the promoter and conserved regulatory region (MSE, myelinating Schwann cell element) of Egr2 (Supplementary Fig. 4) . To test the effect of YY1 on the activity of the Egr2 promoter and MSE, we performed a series of cotransfection experiments with YY1 constructs and luciferase reporter genes, driven either by the mouse Egr2 promoter or by the MSE region upstream of a minimal promoter 19 . We treated cotransfected Schwann cells with NRG1 and measured reporter activity. Consistent with the role of YY1 as an NRG1-dependent downstream activator of Egr2, we detected increased reporter activity in cotransfected cells only after treatment with NRG1 (Fig. 6e) . 
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To determine whether YY1 directly modulated the activity of the Egr2 promoter and MSE in living cells, we performed chromatin immunoprecipitation (ChIP). Chromatin was cross-linked from Schwann cells before or after exposure of Schwann cells to NRG1 for 1 or 12 h. We then tested the recruitment of YY1 to precise chromatin loci using immunoprecipitation with antibodies to YY1 followed by quantitative ChIP with primers specific for the Egr2 locus (Fig. 7a) . YY1 was recruited to the promoter and MSE region of Egr2 only after treatment with NRG1 for 1 h (Fig. 7b) and was consistent with the kinetics of Egr2 transcription in response to NRG1 (Fig. 6a) .
We next investigated how NRG1 treatment promoted binding of YY1 to the Egr2 locus. Because neither the levels nor the subcellular localization of YY1 changed upon NRG1 treatment (Fig. 7c) , we investigated whether its activity was modulated by post-translational modifications induced by NRG1. Analysis of the amino acid sequence of YY1 revealed several potential phosphorylation sites that were highly conserved among species (Fig. 7d) . These sites were consistent with the results of proteomic studies in which YY1 was found to be phosphorylated on S118, S184 and S247 in Hela cells 30, 31 . Analysis of the sequences that surrounded these serine residues, using the Groupbased Prediction System 32 , indicated that these residues were potential MEK phosphorylation sites. Because activation of the MEK-MAPK cascade has been identified as part of NRG1 signaling, we defined the time course of serine phosphorylation of YY1 in Schwann cells exposed to NRG1. Protein extracts from Schwann cells treated with NRG1 for 20 min or 1 h were immunoprecipitated with YY1 antibodies and processed for protein blot analysis using anti-phospho-serine antibodies. We detected an immunoreactive band in the 1-h treatment sample, which indicated YY1 phosphorylation (Fig. 7e) .
To identify the kinase that phosphorylated YY1 in response to NRG1, we tested the functional consequences of pharmacologically blocking the three main pathways downstream of NRG1 (refs. 3,19) . We used inhibitors of Akt activity (LY294002), MEK kinase (U0126 and PD98059) and the phospholipase C (PLC)γ-calcineurin pathway (cyclosporin A (CsA)). Of these compounds, the MEK inhibitors most severely impaired the NRG1-mediated increase in Egr2 expression (Fig. 8a) and blocked YY1 phosphorylation (data not shown). Using ChIP, we also showed that the recruitment of YY1 to the MSE regions a r t I C l e S of the Egr2 locus in response to NRG1 treatment was impaired by treatment with U0126 but not with CsA (Fig. 8b) .
To determine the functional role of NRG1-induced phosphorylation of YY1, we generated multiple Ser→Ala mutantions at position 118, 184 and 247 of YY1 and tested the consequences for the transcriptional activity of YY1 using a YY1 TransLucent Reporter 20 . Mutation of one, two or three serine residues impaired the ability of YY1 to activate a luciferase reporter driven by a cis-acting enhancer element containing multiple YY1 binding sites upstream of a minimal promoter after NRG treatment (Fig. 8c) . Although single Ser→Ala substitutions only moderately affected the ability of YY1 to transactivate luciferase reporters driven by the Egr2 regulatory elements (Fig. 8d) , the mutant construct with three amino acid substitutions produced the most significant impairment (Fig. 8d) . Therefore, phosphorylation of YY1 is a key signal downstream of NRG1 that is required for the upregulation of Egr2.
Our results identify YY1 as a crucial regulator of peripheral nerve myelination that functions as an activator upon NRG1-dependent phosphorylation of key serine residues. DISCUSSION YY1 is a key regulator of postnatal myelination in the PNS The notable peripheral nerve hypomyelination that we detected in mice with conditional ablation of Yy1 provides the first in vivo genetic evidence that YY1 has a crucial role in peripheral nerve myelination. The expression of YY1 in the developing sciatic nerve paralleled that of the key transcriptional regulator Egr2, which has been extensively characterized for its role in promoting the attainment of a myelinating phenotype 10, 21 . The temporal expression profile of YY1 suggested that it might be involved in the late postnatal development of peripheral nerves. Consistent with this prediction, at birth the sciatic nerves of Yy1 loxP/loxP ; Cnp-cre +/− mice and control mice were similar in appearance. The proliferation rates, numbers and gene expression profiles of Schwann cells were also similar between wild-type and Yy1 loxP/loxP ; Cnpcre +/− mice during the first neonatal days. Early Schwann cell development was therefore unperturbed in the Yy1 loxP/loxP ; Cnp-cre +/− mice and the detection of a correct 1:1 relationship with the axons confirmed that Schwann cells underwent radial sorting and axonal segregation.
We observed severe hypomyelination during the second postnatal week, characterized by decreased levels of myelin proteins and of Egr2.
Notably, the presence of hypomyelination after normal segregation, increased proliferation and compensatory apoptosis at P10 resembled the phenotype of Egr2 mutants 10, 14 . A comparison between the gene expression profiles of Yy1 deficient mice and Egr2 hypomorphs revealed marked similarities in the patterns of gene expression in the peripheral nerves of these mutants 14 . The ability of Egr2 to rescue the ability of cultured Yy1 mutant Schwann cells to express myelin proteins suggested that Egr2 is downstream of Yy1. This conclusion was supported by evidence that overexpression of Yy1 activated the expression of luciferase reporter genes driven by the Egr2 promoter and regulatory elements and that YY1 is physically bound to these elements in the chromatin of cultured Schwann cells exposed to NRG1.
YY1 activity is regulated by NRG1-dependent phosphorylation
Myelination of the PNS depends on the interplay between extracellular signals and a complex transcriptional network that modulates Schwann cell maturation. Previous work has shown that NRG1 type III is the axonal signal that binds to its receptors erbB2 and erbB3 and regulates the timing and amount of myelination as well as myelin sheath thickness 2, 4 . Besides its role in myelination, NRG1 also regulates multiple stages of Schwann cell development, including the early commitment of neural crest cells and precursor migration 1, 6 , and several groups have attempted to decipher the signaling events downstream of the activation of erbB2 and erbB3 receptors.
A crucial event in myelination is the upregulation of Egr2. The levels of Egr2 are increased during the transition to myelinating Schwann cells and this increase has been attributed to axonal contact as well as to membrane-bound or soluble neuregulins 4, 17 . Despite the evidence that Egr2 is crucial for peripheral nerve myelination, there is limited information on the NRG1-dependent pathways that regulate Egr2 expression. Three signaling pathways have been shown to be activated by erbB2-erbB3 receptor complexes in response to ligand binding: phosphatidylinositol-3-OH kinase (PI(3)K), PLCγ and MEK 19, [33] [34] [35] . Although many reports have focused on the activation of the PI(3)K pathway, a recent study has implicated the PLCγ pathway, Fig. 6 ). Previous studies had identified the downstream MAPKs as mediators of the proliferative and migratory effects of NRG1 in Schwann cell precursors 35, 36 . Our data are not inconsistent with this possibility, because we focused our analysis at the postnatal stage of development, when YY1 is increased, rather than at earlier embryonic stages. Downstream of MEK kinase, at least two pathways with opposing effects have been identified. The activation of the Ras-MAPK pathway, for instance, has been associated with lack of differentiation 34, 37, 38 , whereas activation of p38 kinase has been associated with myelination 37, 39 . However, these effects were dependent on the concentrations of soluble NRG and the strength of MAPK activation. Together these data suggest that in Schwann cells, as in other experimental systems, exposure to signaling molecules (NRG1) determined an outcome that depended on the strength of the signal, the enzymes that were activated (Akt, PLCγ, MEK), the levels and kinetics of activation of each enzyme and the specificity of the cellular substrates, which may differ at distinct developmental stages. Future studies might be needed to determine the molecular identity and functional significance of NRG-dependent activation at distinct stages in Schwann cell development and in response to exposure to axon-bound or soluble ligands.
The role of YY1 is unique and cell-type specific In oligodendrocytes, the myelin-forming cells of the CNS, YY1 forms repressive complexes with HDAC1 and HDAC2 that downregulate transcriptional inhibitors of myelin gene expression, such as Tcf7l2 and Id4, and favor progression to a myelinating phenotype 20 . In other words, YY1 modulates oligodendrocyte differentiation by promoting a de-repression mechanism (inhibiting the inhibitors). Considering that both oligodendrocytes and Schwann cells can produce myelin and that their differentiation is similarly impaired in the absence of Yy1, the simplest explanation would suggest that YY1 has a similar role in myelin-forming cells of the PNS and CNS. However, we have shown that the role of YY1 in the PNS is quite different from its role in the CNS and that it acts as transcriptional activator of Egr2, a key regulator of Schwann cell myelination. The ability of YY1 to activate the expression of Egr2 is not constitutive, but rather is modulated by phosphorylation events that can be induced by exposure of Schwann cells to NRG1. Therefore, even though the peripheral and central phenotypes of Yy1 mutant mice are similar (hypomyelination), the YY1-dependent mechanisms in the CNS and PNS are distinct and cell specific. In oligodendrocytes, YY1 is part of repressive complexes that contain histone deacetylases and the repression of transcriptional inhibitors depends on its acetylation state 40 . By contrast, in Schwann cells YY1 functions as activator of gene expression whose activity depends on the phosphorylation state of specific serine residues, consistent with early studies on the signals that modulate the yin and yang functions of this zinc-finger protein 41 . The essential function of YY1 in Schwann cell myelination, as revealed by the phenotype of Yy1 conditional knockout mice, does not exclude the possibility that YY1participates in earlier stages of Schwann cell development. Yy1 deletion studies in Xenopus have identified several target genes that are involved in neural crest development, such as slug, snail and Otx2 (refs. 42,43) . It will be interesting to determine whether YY1 has distinct functions at different stages of Schwann cell lineage development and to identify the posttranslational modifications of this transcription factor that might integrate the cross-talk among distinct signaling pathways.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
(for both mouse and rat) and analyzed using the Pfaffl ΔΔCt method. The PCR of ChIP was performed using the same conditions and analyzed by referring the data to the input value for each sample. microarray. Total RNA was isolated from the sciatic nerves of Yy1 loxP/loxP ; Cnp-cre +/− and control mice at P21. RNA (200 ng) from each group (n = 2) was pooled in equimolar amounts and used for hybridization with Affymetrix GeneChip Mouse Genome 430A 2.0 Array, representing approximately 14,000 well-characterized mouse genes (Cancer Institute of New Jersey). Array data were uploaded in ArrayExpress (accession no.: E-MEXP-2919). Differential gene expression was determined using a Bayesian procedure 49 . Genes called absent in all chips were excluded and changes of at least twofold and 5% false discovery rate were defined as significant. The comparison generated a subset of 1,575 probes (called as genes in the text) with increased expression and 1,151 genes with decreased expression. This subset was further compared with the subset of genes that were differentially expressed in Egr2 Lo/Lo and Nab1 −/− ; Nab2 −/− mice at P14 (ref. 17 ). This analysis revealed 351 genes at the intersect and this group was subjected to Gene Ontology Analysis using DAVID Functional Annotation Tools (http://david.abcc.ncifcrf.gov/tools.jsp) 50 .
Statistical methods. Results are expressed as mean ± s.d. and statistically analyzed using two-tailed Student's t tests. P of <0.05 was considered to be statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001.
